Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.94 |
| ▸ | NPC1 | O15118 | 2/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.54 |
| ▸ | MAPT | P10636 | 4/20 | 0.52 |
| ▸ | HTT | P42858 | 3/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.52 |
| ▸ | CASP1 | P29466 | 2/20 | 0.52 |
| ▸ | TP53 | P04637 | 2/20 | 0.52 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | CASP7 | P55210 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.52 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Quinoline SCHEMBL5888530 | 1.00 | ALDH1A1 (0.94) | ALDH1A1NPC1POLBRAB9ACYP3A4 | |
| Quinoline SCHEMBL28663579 | 1.00 | ALDH1A1 (0.94) | ALDH1A1NPC1POLBRAB9ACYP3A4 | |
| Quinoline SCHEMBL27695728 | 0.97 | ALDH1A1 (0.90) | ALDH1A1NPC1POLBRAB9ACYP3A4 | |
| Quinoline SCHEMBL28095975 | 0.97 | ALDH1A1 (0.90) | ALDH1A1NPC1POLBRAB9ACYP3A4 | |
| Quinoline SCHEMBL1270969 | 0.97 | ALDH1A1 (1.00) | ALDH1A1NPC1POLBRAB9ACYP3A4 | |
| Quinoline SCHEMBL29349552 | 0.97 | ALDH1A1 (1.00) | ALDH1A1NPC1POLBRAB9ACYP3A4 | |
| Quinoline SCHEMBL2774 | 0.97 | ALDH1A1 (1.00) | ALDH1A1NPC1POLBRAB9ACYP3A4 | |
| Quinoline SCHEMBL29822171 | 0.97 | ALDH1A1 (1.00) | ALDH1A1NPC1POLBRAB9ACYP3A4 | |
| Quinoline SCHEMBL32661377 | 0.97 | ALDH1A1 (1.00) | ALDH1A1NPC1POLBRAB9ACYP3A4 | |
| Quinoline SCHEMBL23202414 | 0.94 | ALDH1A1 (0.94) | ALDH1A1NPC1POLBRAB9ACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113527370-B | Quinoline iridium complex targeting lung cancer cisplatin drug-resistant cells and synthesis method and application thereof | 玉林师范学院 | 2022-07-15 | — | — | CN | claimed |
| CN-113527370-A | Quinoline iridium complex targeting lung cancer cisplatin drug-resistant cells and synthesis method and application thereof | 玉林师范学院 | 2021-10-22 | — | — | CN | claimed |
| US-10263189-B2 | Organic electroluminescent device and manufacturing method thereof, and display apparatus | BOE TECHNOLOGY GROUP CO., LTD. (CN) | 2019-04-16 | — | — | US | claimed |
| CN-106496277-A | The electroluminescent device of complex of iridium and its preparation method and application complex of iridium | 瑞声光电科技(常州)有限公司 | 2017-03-15 | — | — | CN | claimed |
| CN-106496278-A | The electroluminescent device of complex of iridium and its preparation method and application complex of iridium | 瑞声光电科技(常州)有限公司 | 2017-03-15 | — | — | CN | claimed |
| CN-106432349-A | Iridium complex, preparation method thereof and electroluminescent device employing iridium complex | 瑞声光电科技(常州)有限公司 | 2017-02-22 | — | — | CN | claimed |
| CN-106432351-A | Iridium complexes and preparation method thereof and electroluminescent devices using iridium complexes | 瑞声光电科技(常州)有限公司 | 2017-02-22 | — | — | CN | claimed |
| US-20160005971-A1 | ORGANIC ELECTROLUMINESCENT DEVICE AND MANUFACTURING METHOD THEREOF, AND DISPLAY APPARATUS | BOE TECHNOLOGY GROUP CO., LTD. (CN) | 2016-01-07 | — | — | US | claimed |
| CN-103242369-A | Aromatic five-membered heterocyclo-substituted quinoline iridium (III) complex as well as preparation method and application thereof | UNIV TAIYUAN TECHNOLOGY | 2013-08-14 | — | — | CN | claimed |
| US-20250388612-A1 | METAL IRIDIUM COMPLEX AND APPLICATION THEREOF | SICHUAN AG-RAY NEW MATERIALS CO., LTD (CN) | 2025-12-25 | — | — | US | disclosed |
| US-12477942-B2 | Organic metal compound and application thereof | GUANGDONG AGLAIA OPTOELECTRONIC MATERIALS CO., LTD (CN) | 2025-11-18 | — | — | US | disclosed |
| CN-119285680-A | Iridium complex, preparation method thereof and organic electroluminescent device | 吉林奥来德光电材料股份有限公司 | 2025-01-10 | — | — | CN | disclosed |
| CN-114605474-B | Iridium complex and application thereof | 广东阿格蕾雅光电材料有限公司 | 2024-08-02 | — | — | CN | disclosed |
| CN-113788860-B | Iridium complex and application thereof | 四川阿格瑞新材料有限公司 | 2024-07-05 | — | — | CN | disclosed |
| CN-100492709-C | Organic electroluminescent element and display device | KONICA MINOLTA HOLDINGS INC (JP) | 2009-05-27 | — | — | CN | disclosed |
| CN-100487946-C | Organic electroluminescence component | SANYO ELECTRIC CO (JP) | 2009-05-13 | — | — | CN | disclosed |
| CN-101414667-A | Organic electroluminescent element and display device | KONICA MINOLTA HOLDINGS INC (JP) | 2009-04-22 | — | — | CN | disclosed |
| CN-1701642-A | Organic electroluminescent element and display device | KONICA MINOLTA HOLDINGS INC (JP) | 2005-11-23 | — | — | CN | disclosed |
| CN-1674737-A | Organic electroluminescence component | SANYO ELECTRIC CO (JP) | 2005-09-28 | — | — | CN | disclosed |
| CN-1674744-A | Organic electroluminescence component | SANYO ELECTRIC CO (JP) | 2005-09-28 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250388612-A1 | METAL IRIDIUM COMPLEX AND APPLICATION THEREOF | LUC7L2, SOD1, LAS1L | ALDH1A1 1187/4885NPC1 1700/4885POLB 4033/4885 |
| US-12477942-B2 | Organic metal compound and application thereof | TRPM2, TRPM5, TRPM4 | ALDH1A1 712/4885NPC1 2129/4885POLB 2305/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.